In a settlement negotiation that ran late into the night Monday, according to a source familiar with the discussions, McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation have agreed to pay $1.1 billion towards opioid abatement efforts in the Empire State, according to the statement.
“Today, we’re holding them accountable, delivering more than $1 billion more into New York communities ravaged by opioids for treatment, recovery, and prevention efforts,” James added. “While no amount of money will ever compensate for the millions of addictions, the hundreds of thousands of deaths, or the countless communities decimated by opioids, this money will be vital in preventing any future devastation.”
Tuesday’s settlement also includes funds for New York’s attorney’s fees.
The money will be paid out over the course of the next 17 years, with the first payment coming in September.
The three distributors have also agreed to monitoring of their opioid shipments going forward, with a third-party,…
